Proton therapy for paediatric CNS tumours - improving treatment-related outcomes. (Q38838663)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27197578%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

review article

1 reference

title

Proton therapy for paediatric CNS tumours - improving treatment-related outcomes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27197578%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Vinai Gondi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27197578%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

language of work or name

English

0 references

publication date

20 May 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27197578%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

published in

Nature Reviews Neurology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27197578%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27197578%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27197578%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

334-345

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27197578%20AND%20SRC:MED&resulttype=core&format=json

Chronic health conditions in adult survivors of childhood cancer

2 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Annual Report to the Nation on the Status of Cancer, 1975-2007, Featuring Tumors of the Brain and Other Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Phase II trial of conformal radiation therapy for pediatric low-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Induction chemotherapy followed by low-dose involved-field radiotherapy for intracranial germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Long-term survivors of childhood cancers in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Incidence of atypical teratoid/rhabdoid tumors in children: a population-based study by the Austrian Brain Tumor Registry, 1996-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Primary neurosurgery for pediatric low-grade gliomas: a prospective multi-institutional study from the Children's Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Surveillance imaging strategies following surgery and/or radiotherapy for childhood cerebellar low-grade astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Is craniospinal irradiation required to cure children with malignant (anaplastic) intracranial ependymomas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Role of radiotherapy in anaplastic ependymoma in children under age of 3 years: results of the prospective German brain tumor trials HIT-SKK 87 and 92.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Prognostic factors in infants and very young children with intracranial ependymomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Salvage treatment for childhood ependymoma after surgery only: Pitfalls of omitting "at once" adjuvant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Infant ependymoma in a 10-year AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) experience with omitted or deferred radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Quality of life in long-term survivors of CNS tumors of childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

A quantitative meta-analysis of neurocognitive sequelae in survivors of pediatric brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Neuropsychological status of children treated for brain tumors: a critical review and integrative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

A hybrid neural network analysis of subtle brain volume differences in children surviving brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Vulnerability of white matter to insult during childhood: evidence from patients treated for medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Risk factors for cognitive decline in children treated for brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Neurocognitive function after radiotherapy for paediatric brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Processing speed, attention, and working memory after treatment for medulloblastoma: an international, prospective, and longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Long-term efficacy of methylphenidate in enhancing attention regulation, social skills, and academic abilities of childhood cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Relationships among processing speed, working memory, and fluid intelligence in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Neurocognitive deficits in medulloblastoma survivors and white matter loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Changes in cerebral cortex of children treated for medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Why avoid the hippocampus? A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Association between radiation dose to neuronal progenitor cell niches and temporal lobes and performance on neuropsychological testing in children: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Early Cognitive Outcomes Following Proton Radiation in Pediatric Patients With Brain and Central Nervous System Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Comparing Intelligence Quotient Change After Treatment With Proton Versus Photon Radiation Therapy for Pediatric Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Hypopituitarism following radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Endocrine deficit after fractionated total body irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Treatment-induced hearing loss and adult social outcomes in survivors of childhood CNS and non-CNS solid tumors: Results from the St. Jude Lifetime Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Hearing Loss in Patients Who Received Cranial Radiation Therapy for Childhood Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Early neuro-otologic effects of three-dimensional irradiation in children with primary brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Ototoxicity of preradiation cisplatin for children with central nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Late Cerebrovascular Complications After Radiotherapy for Childhood Primary Central Nervous System Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Large intracranial vessel occlusive vasculopathy after radiation therapy in children: Clinical features and usefulness of magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Risk of ischemic heart disease in women after radiotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Dosimetric Comparison of Three-Dimensional Conformal Proton Radiotherapy, Intensity-Modulated Proton Therapy, and Intensity-Modulated Radiotherapy for Treatment of Pediatric Craniopharyngiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Long-term survivors of childhood central nervous system malignancies: the experience of the Childhood Cancer Survivor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

An analysis of SEER data of increasing risk of secondary malignant neoplasms among long-term survivors of childhood brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Incidence of second malignancies among patients treated with proton versus photon radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Risk of second cancers after photon and proton radiotherapy: a review of the data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Quality of life outcomes in proton and photon treated pediatric brain tumor survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Exponential Increase in Relative Biological Effectiveness Along Distal Edge of a Proton Bragg Peak as Measured by Deoxyribonucleic Acid Double-Strand Breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Imaging Changes in Pediatric Intracranial Ependymoma Patients Treated With Proton Beam Radiation Therapy Compared to Intensity Modulated Radiation Therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Radiation Necrosis in Pediatric Patients with Brain Tumors Treated with Proton Radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Imaging changes in very young children with brain tumors treated with proton therapy and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Range modulation in proton therapy planning: a simple method for mitigating effects of increased relative biological effectiveness at the end-of-range of clinical proton beams

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Relevance of Particle Therapy to Developing Countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Proton Beam Therapy in Small Nations: Financial Irrationality or Unique Collaborative Opportunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Early clinical outcomes using proton radiation for children with central nervous system atypical teratoid rhabdoid tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Relationship between the brain radiation dose for the treatment of childhood cancer and the risk of long-term cerebrovascular mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Cardiac dysfunction following spinal irradiation during childhood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Survival and late mortality in long-term survivors of pediatric CNS tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

The risk of radiation-induced second cancers in the high to medium dose region: a comparison between passive and scanned proton therapy, IMRT and VMAT for pediatric patients with brain tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Proton therapy of cancer: potential clinical advantages and cost-effectiveness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

Anteriorly Oriented Beam Arrangements with Daily in Vivo Range Verification for Proton Therapy of Prostate Cancer: Rectal Toxicity Rates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.70

M4 protocol for cerebellar medulloblastoma: supratentorial radiotherapy may not be avoided

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27197578

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27197578